Matas AJ - Search Results

1

Valganciclovir administration to kidney donors to reduce the burden of cytomegalovirus and Epstein-Barr virus transmission during transplantation.

Verghese PS, Schmeling DO, Knight JA, Matas AJ, Balfour HH Jr. Verghese PS, et al. Among authors: matas aj. Transplantation. 2015 Jun;99(6):1186-91. doi: 10.1097/TP.0000000000000490. Transplantation. 2015. PMID: 25489844 Clinical Trial.

2

Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation.

Simmons RL, Matas AJ, Rattazzi LC, Balfour HH Jr, Howard JR, Najarian JS. Simmons RL, et al. Among authors: matas aj. Surgery. 1977 Nov;82(5):537-46. Surgery. 1977. PMID: 199956

3

Encephalomyocarditis virus-induced diabetes mellitus treated by islet transplantation.

Howard RJ, Balfour HH Jr, Matas AJ, Najarian JS, Sutherland DE. Howard RJ, et al. Among authors: matas aj. Transplantation. 1979 Mar;27(3):200-2. doi: 10.1097/00007890-197903000-00012. Transplantation. 1979. PMID: 219567

4

Reversal of encephalomyocarditis virus-induced diabetes mellitus by islet transplantation.

Howard RJ, Matas AJ, Balfour HH Jr, Cohn R, Najarian JS, Sutherland DE. Howard RJ, et al. Among authors: matas aj. Transplant Proc. 1979 Mar;11(1):557-9. Transplant Proc. 1979. PMID: 222018 No abstract available.

5

Retransplantation as a risk factor for lymphocele formation.

Stephanian E, Matas AJ, Gores P, Sutherland DE, Najarian JS. Stephanian E, et al. Among authors: matas aj. Transplantation. 1992 Mar;53(3):676-8. doi: 10.1097/00007890-199203000-00035. Transplantation. 1992. PMID: 1549865 No abstract available.

6

Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis.

Stephanian E, Matas AJ, Mauer SM, Chavers B, Nevins T, Kashtan C, Sutherland DE, Gores P, Najarian JS. Stephanian E, et al. Among authors: matas aj. Transplantation. 1992 Apr;53(4):755-7. doi: 10.1097/00007890-199204000-00009. Transplantation. 1992. PMID: 1566339

7

Morbidity following simultaneous pancreas-kidney transplants vs kidney transplants alone in diabetic patients.

Cheung AH, Sutherland DE, Dunn DL, Moudry-Munns KC, McHugh LE, Gillingham KJ, Najarian JS, Matas AJ. Cheung AH, et al. Among authors: matas aj. Transplant Proc. 1992 Jun;24(3):866-8. Transplant Proc. 1992. PMID: 1604647 Clinical Trial. No abstract available.

8

Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model.

Leventhal JR, Flores HC, Gruber SA, Figueroa J, Platt JL, Manivel JC, Bach FH, Matas AJ, Bolman RM 3rd. Leventhal JR, et al. Among authors: matas aj. Transplantation. 1992 Jul;54(1):26-31. doi: 10.1097/00007890-199207000-00004. Transplantation. 1992. PMID: 1631940

9

Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients.

Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DE, Najarian JS. Frey DJ, et al. Among authors: matas aj. Transplantation. 1992 Jul;54(1):50-6. doi: 10.1097/00007890-199207000-00008. Transplantation. 1992. PMID: 1631944 Clinical Trial.

10

Mizoribine pharmacokinetics and pharmacodynamics in a canine renal allograft model of local immunosuppression.

Gruber SA, Erdmann GR, Burke BA, Moss A, Bowers L, Hrushesky WJ, Cipolle RJ, Canafax DM, Matas AJ. Gruber SA, et al. Among authors: matas aj. Transplantation. 1992 Jan;53(1):12-9. doi: 10.1097/00007890-199201000-00002. Transplantation. 1992. PMID: 1733057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

711 results

Search Page

Filters